Renaissance Technologies LLC Increases Position in DocGo Inc. $DCGO

Renaissance Technologies LLC raised its holdings in shares of DocGo Inc. (NASDAQ:DCGO) by 167.1% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,510,361 shares of the company’s stock after purchasing an additional 944,826 shares during the period. Renaissance Technologies LLC’s holdings in DocGo were worth $950,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. AQR Capital Management LLC increased its position in DocGo by 219.1% during the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company’s stock valued at $1,258,000 after buying an additional 327,269 shares in the last quarter. Jane Street Group LLC grew its stake in shares of DocGo by 18.8% in the first quarter. Jane Street Group LLC now owns 85,442 shares of the company’s stock worth $226,000 after acquiring an additional 13,505 shares during the last quarter. Acadian Asset Management LLC purchased a new stake in shares of DocGo in the first quarter worth $338,000. Strs Ohio bought a new position in shares of DocGo during the first quarter valued at $76,000. Finally, JPMorgan Chase & Co. increased its holdings in shares of DocGo by 16.8% during the second quarter. JPMorgan Chase & Co. now owns 290,354 shares of the company’s stock valued at $456,000 after acquiring an additional 41,679 shares in the last quarter. 56.44% of the stock is owned by institutional investors.

DocGo Trading Up 2.2%

DocGo stock opened at $0.67 on Friday. DocGo Inc. has a 12 month low of $0.45 and a 12 month high of $1.73. The stock has a fifty day simple moving average of $0.60 and a two-hundred day simple moving average of $0.64. The firm has a market cap of $65.91 million, a price-to-earnings ratio of -0.35 and a beta of 0.99.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on DCGO. Wall Street Zen upgraded shares of DocGo from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Cantor Fitzgerald restated an “overweight” rating on shares of DocGo in a research note on Monday, May 11th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DocGo in a report on Thursday, June 18th. Three research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, DocGo presently has a consensus rating of “Hold” and a consensus price target of $2.38.

DocGo Profile

DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.

In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.